Australian Government-Funded Vaping Education Program Featured in The Lancet: Student Vaping Rates Drop by 65%

Jul.29.2025
Australia’s “OurFutures” vaping education program cut student vaping rates by 65% after 12 months, according to a trial of 5,000 students across 40 schools. Published in The Lancet, it is the first proven effective school-based e-health intervention in Australia. The program will be expanded through 2028, with long-term data expected in 2026.

Key Points:

 

·Project results: The "Our Futures Vaping Prevention Education program" in Australia has significantly reduced the likelihood of teenagers using e-cigarettes, with students involved in the program being 65% less likely to use e-cigarettes 12 months later compared to students who did not participate. 

 

·Research background: The program is funded by the current Australian government and is the first confirmed school-based electronic health intervention program in Australia that can prevent teenagers from using e-cigarettes. 

 

·Research methods: The randomized controlled trial involved 40 schools and over 5000 students, with the results published in The Lancet. 

 

·Project content: The program engages students through cartoon stories, quizzes, and classroom activities, co-designed by young people and teachers to align with national curriculum guidelines. 

 

·Public health significance: The latest data shows a decline in young people using e-cigarettes, with e-cigarette use being increasingly viewed as uncool and socially unacceptable among youth. 

 

·Future plans: The project will be expanded nationwide until 2028, with long-term tracking data expected to be available by 2026.

 


 

【2Firsts News Flash】According to the official website of the Australian government on July 29th, Australia's "Our Futures Vaping Prevention Education program" implemented in schools has achieved tangible results in preventing young people from using e-cigarettes.

 

This randomized controlled trial involved over 5,000 students from 40 schools, and its results were published on July 29th in the top health journal, The Lancet. The study found that students who participated in the program were 65% less likely to use e-cigarettes after 12 months compared to students who did not take part in the course. Additionally, 80% of students reported that the knowledge they gained would help them deal with e-cigarette-related situations in the future.

 

This project is funded by the current Australian government through the Medical Research Future Fund and the National Health and Medical Research Council. It is the first Australian school-based electronic health intervention program proven to prevent adolescents from using e-cigarettes.

 

This program attracts students and delivers information through cartoon stories, quizzes, and classroom activities. It is designed by young people and teachers together to align with the national curriculum.

 

These positive findings are consistent with the latest data on "Generation Vape," which shows a decreasing trend in youth e-cigarette use. E-cigarettes are increasingly being seen as uncool and socially unacceptable among young people.

 

"Our Future" e-cigarette project will be rolled out nationwide until 2028, with long-term tracking data expected to be available by 2026.

 

All high schools are eligible to register and participate in this project, and can do so by signing up immediately.

 

Minister Butler's statement:

 

"'Our Future' e-cigarette prevention education program is helping Australian teenagers make wise choices and resist e-cigarettes. It is smart, scalable, and evidence shows it is effective. This is the evidence-based prevention action we need to protect children's health. Young people are moving away from e-cigarettes. They see its nature - harmful, addictive, and pushed by big tobacco companies. This is proof of the power of education, community, and strong government action."

 

According to publicly available information, The Lancet is one of the oldest and most respected peer-reviewed medical journals in the world, alongside the New England Journal of Medicine, JAMA (Journal of the American Medical Association), and the British Medical Journal, often referred to as the "Big Four" international medical journals.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Cambodia Moves to Draft New Tobacco Control Strategy Targeting Illicit Products and E-Cigarette Spread
Cambodia Moves to Draft New Tobacco Control Strategy Targeting Illicit Products and E-Cigarette Spread
Cambodian Health Minister Cheang Ra has called for the development of a tobacco control strategy for 2027–2031, with the goal of reducing tobacco use by 30% by 2030. The directive was issued during a Tobacco Product Control Committee meeting in Phnom Penh. Priority areas include reducing tobacco use, protecting the public from secondhand smoke, tackling illegal and counterfeit tobacco products, and preventing the spread of e-cigarettes.
Apr.29 by 2FIRSTS.ai
Nearly 35.00% of Surveyed Retailers Shifted to Online Sales After Tighter Controls in Vietnam
Nearly 35.00% of Surveyed Retailers Shifted to Online Sales After Tighter Controls in Vietnam
A study of nearly 2,500 university students in Hanoi, Da Nang, Hue, and Ho Chi Minh City found that the average age of first use of e-cigarettes and heated tobacco products was 16.90. The findings were presented on April 9 in Hanoi. The study also found that 14.00% of students had tried e-cigarettes and 3.00% were current users, while the figures for heated tobacco were 6.00% and 0.80%. % of surveyed retail outlets moving to online sales.
Apr.10 by 2FIRSTS.ai
FDA Adds 18 Tobacco Harmful Constituents and Seeks Comment on 3 More
FDA Adds 18 Tobacco Harmful Constituents and Seeks Comment on 3 More
U.S. Food and Drug Administration published a Federal Register notice finalizing the addition of 18 constituents to the established list of Harmful and Potentially Harmful Constituents in tobacco products. With the update, the list now contains 111 constituents. FDA also proposed adding three more constituents to the list and opened a public comment period ending at 11:59 p.m. ET on May 26, 2026.
Apr.24 by 2FIRSTS.ai
Altria Reports Q1 2026 Net Revenues of $5.43 Billion and 7.3% Growth in Adjusted Diluted EPS
Altria Reports Q1 2026 Net Revenues of $5.43 Billion and 7.3% Growth in Adjusted Diluted EPS
Altria Group reported its first-quarter 2026 results on April 30. Net revenues were $5.43 billion, up 3.2% year on year, while revenues net of excise taxes were $4.76 billion, up 5.3%. Reported diluted EPS was $1.30, up more than 100%, and adjusted diluted EPS was $1.32, up 7.3%.
May.06 by 2FIRSTS.ai
FDA Filing Shows RIF Notices for 229 CTP Employees Were Largely Rescinded
FDA Filing Shows RIF Notices for 229 CTP Employees Were Largely Rescinded
A court declaration signed by FDA official Melanie M. Keller on March 24, 2026 detailed the status of previously issued reduction-in-force notices affecting employees at the Center for Tobacco Products (CTP).
Apr.01 by 2FIRSTS.ai
European Commission Publishes Tobacco Control Framework Evaluation, Says Smoking and Tobacco-Related Deaths Have Declined
European Commission Publishes Tobacco Control Framework Evaluation, Says Smoking and Tobacco-Related Deaths Have Declined
The European Commission has published its evaluation of the EU tobacco control framework, assessing the effectiveness, efficiency and relevance of the Tobacco Products Directive and Tobacco Advertising Directive in protecting public health and ensuring the smooth functioning of the internal market.
Apr.03 by 2FIRSTS.ai